Abstract:The α2-adrenoceptor agonist dexmedetomidine is a commonly used drug for sedatives in clinics and has analgesic effects; however, its mechanism of analgesia in the spine remains unclear. In this study, we systematically used behavioural and transcriptomic sequencing, pharmacological intervention, electrophysiological recording and ultrasound imaging to explore the analgesic effects of the α2-adrenoceptor and its molecular mechanism. Firstly, we found that spinal nerve injury changed the spinal transcriptome expression, and the differential genes were mainly related to calcium signalling and tissue metabolic pathways. In addition, α2-adrenoceptor mRNA expression was significantly upregulated, and α2-adrenoceptor was significantly colocalised with markers, particularly neuronal markers. Intrathecal dexmedetomidine suppressed neuropathic pain and acute inflammatory pain in a dose-dependent manner. The transcriptome results demonstrated that the analgesic effect of dexmedetomidine may be related to the modulation of neuronal metabolism. Weighted gene correlation network analysis indicated that turquoise, brown, yellow and grey modules were the most correlated with dexmedetomidine-induced analgesic effects. Bioinformatics also annotated the involvement of metabolic processes and neural plasticity. A cardiovascular–mitochondrial interaction was found, and ultrasound imaging revealed that injection of dexmedetomidine significantly enhanced spinal cord perfusion in rats with neuropathic pain, which might be regulated by pyruvate dehydrogenase kinase 4 (pdk4), cholesterol 25-hydroxylase (ch25 h) and GTP cyclohydrolase 1 (gch1). Increasing the perfusion doses of dexmedetomidine significantly suppressed the frequency and amplitude of spinal nerve ligation-induced miniature excitatory postsynaptic currents. Overall, dexmedetomidine exerts analgesic effects by restoring neuronal metabolic processes through agonism of the α2-adrenoceptor and subsequently inhibiting changes in synaptic plasticity.

Dexmedetomidine Inhibits ASIC Activity via Activation of α2A Adrenergic Receptors in Rat Dorsal Root Ganglion Neurons

Dexmedetomidine inhibits Tetrodotoxin-resistant Na v 1.8 sodium channel activity through G i/o -dependent pathway in rat dorsal root ganglion neurons

Dexmedetomidine relieves inflammatory pain by enhancing GABAergic synaptic activity in pyramidal neurons of the anterior cingulate cortex

Dexmedetomidine inhibits visceral pain via suppression of PKC and JAK2/STAT3 signaling pathways

Dexmedetomidine relieves formaldehyde-induced pain in rats through both α2 adrenoceptor and imidazoline receptor.

Suppression of ASIC activity by the activation of A1 adenosine receptors in rat primary sensory neurons

Dexmedetomidine Attenuates Persistent Postsurgical Pain by Upregulating K+–Cl− Cotransporter-2 in the Spinal Dorsal Horn in Rats

Dexmedetomidine modulates transient receptor potential vanilloid subtype 1

Dexmedetomidine relieves neuropathic pain by inhibiting hyperpolarization-activated cyclic nucleotide-gated currents in dorsal root ganglia neurons.

Inhibition by dexmedetomidine of the activation of spinal dorsal horn glias and the intracellular ERK signaling pathway induced by nerve injury.

Potentiation of Acid-Sensing Ion Channel Activity by the Activation of 5-HT2 Receptors in Rat Dorsal Root Ganglion Neurons

Dexmedetomidine blocks hyperalgesia and dorsal root ganglia ERK signal activation in a rat model of neuropathic pain

Inhibition of ASIC-Mediated Currents by Activation of Somatostatin 2 Receptors in Rat Dorsal Root Ganglion Neurons

CXCL10 Enhances Acid-Sensing Ion Channel Currents in Rat Dorsal Root

Dexmedetomidine produced analgesic effect via inhibition of HCN currents.

Involvement of Spinal Microglia and Interleukin-18 in the Anti-Nociceptive Effect of Dexmedetomidine in Rats Subjected to CCI

Effect of Dexmedetomidine on Synaptic Transmission in Spinal Dorsal Horn of Rats

Pre‐emptive Analgesia and Its Supraspinal Mechanisms: Enhanced Descending Inhibition and Decreased Descending Facilitation by Dexmedetomidine

Dexamethasone Inhibits IL-8 Via Glycolysis and Mitochondria-Related Pathway to Regulate Inflammatory Pain.

Alpha 2-adrenoceptor participates in anti-hyperalgesia by regulating metabolic demand

Dexmedetomidine Relieved Neuropathic Pain and Inflammation Response Induced by CCI Through HMGB1/TLR4/NF-κB Signal Pathway.